CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
about
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsNeurosteroids in the context of stress: implications for depressive disordersTreatment-resistant Late-life Depression: Challenges and PerspectivesInflammatory biomarkers and depressionPronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.Chronic fatigue syndrome: new insights and old ignorance.Psychological factors in asthmaRepeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implicationsCerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.Neuropeptides involved in the pathophysiology of schizophrenia and major depression.Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression.Cushing’s disease and melancholia.Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms.Corticotrophin releasing factor in man and its measurement: a review.Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.Neuroactive substances in cerebrospinal fluid. Normal and pathological regulatory mechanisms.Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men.L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients.Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism.[Immunological aspects of depressive disorders].Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression.Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.CSF corticotropin-releasing factor in personality disorder: relationship with self-reported parental care.Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.
P2860
Q24618470-AD2D400F-AAB1-4384-B860-7F41F6581CF4Q24646222-C3CE2726-1BE2-47F5-9E8A-2492C0901ECCQ26783006-04C09D73-34C2-4C43-A1AC-797DFDF99332Q28288750-3CD10CAC-BDDF-454B-A4B1-4249DF184AACQ30454280-62327371-8A06-48FD-861D-8EED2AC53430Q30490519-4090644E-D50A-4CF7-80ED-645B2BCF25BFQ31099140-6E9D6DF8-572F-4678-932E-0CC4AA7E2235Q33785889-6C3D5521-4865-4776-952B-11B3CCE9B5D4Q33848593-35471433-0737-4566-AA84-F7903E36AF59Q34185892-59ECA6FA-9C3E-4619-A4D9-C52DC69A9677Q34287292-E89F4F72-B55E-4422-88E8-A2C0D2C70544Q35130197-1B446E20-FE86-414D-B047-315E063C449FQ35819190-3F959F48-C8D1-44B4-98B6-1DEF88AEBC28Q36800963-2A9BCE38-E04A-46BD-B3E6-E7A4895AD271Q36892482-FA32BD90-F2CA-4EEF-A7D5-AE1A6C972478Q37710849-75F4CA9A-F0F6-47F4-8E30-3C98BE40E4F5Q37995205-B0269CB9-E539-4A40-BFC0-CA1D0C3F25EDQ38578590-4E269071-4779-4A4B-96CF-573A42BA8A50Q38748666-155199C4-5FB4-496F-A6BB-572070901236Q39340736-C2C58BD4-A411-4AAF-8A4F-912711E6137FQ39468402-2A7C7478-97EF-4CEA-B897-BDB0FA04BFAAQ40967879-ED371BD2-610D-4221-B544-2917AB752F1DQ40971048-20866283-346F-452D-99DE-2D7521F671C1Q43808438-9B052FD5-9487-420D-9A5C-F452C0375EDEQ44965384-7FB6BCE9-C56E-47E2-8C97-DB9E52ED74C3Q46690356-3DFD6357-E422-4D8D-BB20-3FB32224D017Q46956150-247F7B15-46E3-4624-AA26-74C2C5125F93Q48017291-7266AEF0-DEF3-45BD-BCBB-D0C3137F343BQ48279685-1D718898-5C8F-453B-8D69-089210E2521AQ51792950-6AEB31CE-78C1-4F8D-A44E-E49535383F85Q54042866-6695F0C1-3B41-4EAA-99BB-48888C4509AC
P2860
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
@en
type
label
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
@en
prefLabel
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
@en
P2093
P356
P1476
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
@en
P2093
P304
P356
10.1176/AJP.144.5.641
P407
P577
1987-05-01T00:00:00Z